Literature DB >> 27049088

Expression profiles of SMAD1 protein in lung cancer tissues and normal tissues and its effect on lung cancer incidence.

Y Q Gao1, M Liu2, H Zhang1.   

Abstract

The aim of this study is to detect the expression profiles of SMAD1 protein in lung cancer tissues and normal tissues to investigate its effect on the incidence of lung cancer. The expression profiles of SMAD1 protein in 60 cases of lung cancer tissues (lung cancer group), 25 cases of normal alveolus tissues (alveolus control group) and 29 cases of normal bronchial tissues (bronchial control group) were detected by adopting immunohistochemical analyses, and their relationships with clinicopathologic data were analyzed. The expression of SMAD1 protein in the lung cancer group and the lung squamous cell carcinoma group was significantly lower than that in the alveolus control group and the bronchial control group (P < 0.01). The expression of SMAD1 protein in the lung adenocarcinoma group was significantly lower than that in the alveolus control group and the bronchial control group (P < 0.01); The expression SMAD1 protein showed a significant correlation with lung cancer differentiation and lymphatic metastasis (P < 0.05), but not with genders, ages, tumor sizes and histological types of lung cancer patients (P>0.05).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27049088

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  3 in total

1.  NANOG regulates the proliferation of PCSCs via the TGF-β1/SMAD pathway.

Authors:  Changming Liu; Mingxiong Sheng; Liheng Lin; Huizhang Li; Shanming Guo; Jiabin Zhang; Guangbing Chen; Huihong Chen
Journal:  Open Med (Wars)       Date:  2020-09-01

2.  Construction and analysis of the ceRNA network hsa_circ_0031968/miR-3611/GCG in lung adenocarcinoma.

Authors:  Yang Yang; Yuan Zhang; Xuqing Ding; Yukai Ren; Bochong Wei; Zongxiang Lin; Yunfei Nie; Yuxia Fan
Journal:  Ann Transl Med       Date:  2021-12

3.  Distinct expression and prognostic value of members of SMAD family in non-small cell lung cancer.

Authors:  Zhenguo Zeng; Yuting Yang; Cheng Qing; Zhiguo Hu; Yiming Huang; Chaoqi Zhou; Dan Li; Yanxia Jiang
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.